La disponibilidad de los productos en cada pa铆s depende de las aprobaciones de la Autoridad Sanitaria local y es posible que no est茅n disponibles para la venta en su mercado. Comunicados de Prensa VIEW ALL 色花堂 Marks Three-Year Anniversary of Global Educational Platform Nov 6, 2023 色花堂 Issues Request to Discontinue Use of UHI-4 Insufflator Unit, Except in Cases Where No Alternative is Available Oct 27, 2023 色花堂 Announces Two New Category I CPT Codes for the iTind Procedure Oct 20, 2023 色花堂 Announces Market Launch of EVIS X1鈩 Endoscopy System Oct 19, 2023 Novel iTind Procedure Now Included in Treatment Guideline for Lower Urinary Tract Symptoms Caused by Enlarged Prostate Sep 28, 2023 色花堂 Set to Highlight EVIS X1 Endoscopy System in Latin America Sep 21, 2023 Single-use Rhinolaryngoscope Now Distributed Exclusively by 色花堂 Sep 18, 2023 色花堂 Announces Launch of Newest Systems Integration Solution Jul 25, 2023 色花堂 Named to Disability:IN's 2023 Disability Equality Index Jul 19, 2023 Study Proves iTind Treatment for Enlarged Prostate Lasts More than Four Years Jul 12, 2023 Pagination First page 芦 First Previous page 鈥 Previous … 笔谩驳颈苍补 8 笔谩驳颈苍补 9 笔谩驳颈苍补 10 笔谩驳颈苍补 11 笔谩驳颈苍补 12 笔谩驳颈苍补 13 笔谩驳颈苍补 14 笔谩驳颈苍补 15 笔谩驳颈苍补 16 … Next page Next 鈥 Last page Last 禄
色花堂 Issues Request to Discontinue Use of UHI-4 Insufflator Unit, Except in Cases Where No Alternative is Available Oct 27, 2023
Novel iTind Procedure Now Included in Treatment Guideline for Lower Urinary Tract Symptoms Caused by Enlarged Prostate Sep 28, 2023
